You are here: Industry Insights > depression

News List

Top 15 C B D Oil For Anxiety Reviews Health Canal
October 14, 2020
If you enjoy trying new, exciting c b d oil, C B D product will feel like a dream come true.
Does C B D Oil Really Bring Good Results for Depression PharmaSources/Keith J. Myers
October 14, 2020
More and more people are using C B D or cannabidiol products to aid in their recovery from depression. And though there is a lack of clinical trials, there is a substantial number of studies that show that C B D could help in recovering from depression.
Newer Hormone Treatments for Prostate Cancer May Raise Risk of Depression drugs.com
January 18, 2022
Advanced forms of hormone therapy are very effective at keeping prostate cancer in check, but they also can double a man's risk of falling into depression, researchers have found.
Tailored Strategies Can Up Depression Referrals in Breast Cancer drugs
January 04, 2022
For patients with newly diagnosed breast cancer, tailored strategies for implementation of routine depression screening result in a greater proportion of referrals to behavioral care, according to a study published in the Jan. 4 issue of the Journal of th
Ketamine May Quickly Ease Tough-to-Treat Depression drugs
December 27, 2021
Ketamine, once most famous as a "club" drug, can rapidly improve hard-to-treat depression and curb suicidal thoughts, a new review confirms.
Online Programs, Phone Apps Can Help Treat Depression Drugs
December 15, 2021
People with depression symptoms might find some help from online programs or smartphone apps — but the human component remains key, a new research review suggests.
Social Media Use Tied to Self-Reported Depression Symptoms Drugs
December 08, 2021
Social media use is associated with a greater likelihood of subsequent increase in depressive symptoms among adults initially free of depression, according to a study published online Nov. 23 in JAMA Network Open.
Intranasal anti-depressant drug successfully delivered to the brain EuropeanPharmaceuticalReview
November 15, 2021
A team of researchers at the Tokyo University of Science (TUS), Japan, have achieved success in the intranasal delivery of the anti-depressant drug glucagon-like peptide 2 (GLP-2) in a mouse model of depression.
NEWS Depression drug shows positive results in groundbreaking Phase IIb study EuropeanPharmaceuticalReview
November 11, 2021
COMPASS Pathways has announced that its groundbreaking Phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression has achieved its primary endpoint...
AHA News: Researchers Start to Uncover the Pandemic's Impact on Mental Health Drugs
November 11, 2021
Depression remained common during the pandemic and worsened for some people, according to a new study aiming to cast light on links between the pandemic and mental health.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page